The cost of Exparel can vary depending on several factors, including the specific medical procedure, the healthcare setting, and insurance coverage. As a non-opioid injectable anesthetic, Exparel is designed for prolonged pain relief, which can influence its overall cost-effectiveness compared to managing pain with traditional methods.
How does Exparel's cost compare to other pain management options?
Exparel provides extended pain relief following surgery, potentially reducing the need for additional pain medications and associated costs. While the upfront cost of Exparel may be higher than some shorter-acting anesthetics or opioid prescriptions, its duration of action can lead to savings by minimizing hospital readmissions, fewer office visits for pain management, and reduced overall opioid consumption and its related risks [1].
What factors influence the price of Exparel?
The price of Exparel is influenced by the dosage administered, which is determined by the surgical site and the procedure performed. The facility where the procedure takes place, whether it's a hospital or an outpatient surgical center, can also affect the final cost due to differing overhead and pricing structures. Additionally, patient insurance plans play a significant role, as co-pays, deductibles, and out-of-pocket maximums will determine the patient's financial responsibility [2].
When does Exparel's patent protection end?
Information regarding the specific patent expiration dates for Exparel can be found on specialized resources like DrugPatentWatch.com [3]. Patents protect the exclusivity of a drug, and their expiration allows for the potential development of generic alternatives, which could impact pricing in the future.
Who manufactures Exparel?
Exparel is manufactured by Pacira BioSciences, Inc. [2].
What clinical data supports Exparel's use and cost-effectiveness?
Clinical trials have demonstrated Exparel's efficacy in providing significant pain relief for extended periods after various surgical procedures, such as orthopedic surgery, hernia repair, and breast surgery. Studies often assess not only pain scores but also the reduction in opioid use and patient satisfaction. These data points are crucial for healthcare providers and payers when evaluating the value and cost-effectiveness of Exparel [1].
What are patient concerns regarding Exparel?
Patients may have questions about the overall cost of their surgical procedure, including the specific charge for Exparel. Understanding insurance coverage and potential out-of-pocket expenses is a common patient concern. Information on patient assistance programs or cost-saving options might also be sought by patients [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/